Howard Hughes Medical Institute and Department of Microbiology and Immunology, University of California, San Francisco, California 94143, USA.
J Biol Chem. 2010 Jul 16;285(29):22328-37. doi: 10.1074/jbc.M110.123299. Epub 2010 May 12.
Lymphocyte egress from lymph nodes requires the G-protein-coupled sphingosine 1-phosphate receptor-1 (S1P(1)). The activation antigen CD69 associates with and inhibits the function of S1P(1), inhibiting egress. Here we undertook biochemical characterization of the requirements for S1P(1)-CD69 complex formation. Domain swapping experiments between CD69 and the related type II transmembrane protein, NKRp1A, identified a requirement for the transmembrane and membrane proximal domains for specific interaction. Mutagenesis of S1P(1) showed a lack of requirement for N-linked glycosylation, tyrosine sulfation, or desensitization motifs but identified a requirement for transmembrane helix 4. Expression of CD69 led to a reduction of S1P(1) in cell lysates, likely reflecting degradation. Unexpectedly, the S1P(1)-CD69 complex exhibited a much longer half-life for binding of S1P than S1P(1) alone. In contrast to wild-type CD69, a non-S1P(1) binding mutant of CD69 failed to inhibit T cell egress from lymph nodes. These findings identify an integral membrane interaction between CD69 and S1P(1) and suggest that CD69 induces an S1P(1) conformation that shares some properties of the ligand-bound state, thereby facilitating S1P(1) internalization and degradation.
淋巴细胞从淋巴结中迁出需要 G 蛋白偶联鞘氨醇 1-磷酸受体 1(S1P(1))。激活抗原 CD69 与 S1P(1)结合并抑制其功能,从而抑制迁出。在这里,我们对 S1P(1)-CD69 复合物形成的要求进行了生化特征分析。CD69 和相关的 II 型跨膜蛋白 NKRp1A 之间的结构域交换实验确定了特定相互作用需要跨膜和膜近端结构域。S1P(1)的突变实验表明,它不需要 N 连接糖基化、酪氨酸硫酸化或脱敏基序,但需要跨膜螺旋 4。CD69 的表达导致细胞裂解物中 S1P(1)减少,可能反映了降解。出乎意料的是,与 S1P(1) 相比,S1P(1)-CD69 复合物结合 S1P 的半衰期要长得多。与野生型 CD69 相反,CD69 的非 S1P(1)结合突变体未能抑制 T 细胞从淋巴结中迁出。这些发现确定了 CD69 和 S1P(1) 之间的完整膜相互作用,并表明 CD69 诱导 S1P(1)构象,该构象具有配体结合状态的某些特性,从而促进 S1P(1)内化和降解。
J Exp Med. 2014-3-17
J Med Chem. 2025-8-28
J Biol Chem. 2025-7-4
Cell Commun Signal. 2025-2-26
J Clin Invest. 2025-1-16
Proc Natl Acad Sci U S A. 2024-10-15
N Engl J Med. 2010-1-20
Mol Cell Endocrinol. 2009-3-5
Nature. 2008-7-24
Curr Protoc Bioinformatics. 2006-10